JAK2 seems to be a typical cooperating mutation in therapy-related t(8;21)/ AML1-ETO-positive AML.

  • S Schnittger
  • Ulrike Bacher
  • W Kern
  • C Haferlach
  • T Haferlach

Bibliographical data

Original languageGerman
Article number1
ISSN0887-6924
Publication statusPublished - 2007
pubmed 17096014